Filed: 11/13/2025ACC: 0001846444-25-000022
📋 What this filing means
SANDS CAPITAL ALTERNATIVES, LLC filed this quarterly 13F‑HR report disclosing 20 equity positions with a total reported market value of $456.42M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
20
Positions
$456.42M
Total AUM (reported)
35.20M
Total Shares
Allocation by class
ORD SHS CL A$114.88M25.2%
COM SER A$97.33M21.3%
COM$93.58M20.5%
CL A$63.49M13.9%
CL A COM$22.54M4.9%
COM CL A$22.31M4.9%
COM NEW$17.74M3.9%
Portfolio Concentration
Top 3$283.15M62.0%
4–10$128.47M28.1%
11–25$44.80M9.8%
Top 3 weight
62.0%
Top 10 weight
90.2%
Voting Authority Distribution
Total shares with voting rights: 35.20M
Sole
Full voting authority
35.20M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole20
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings20
Rows:
NU HLDGS LTD
SOLEShares7.18M
TypeSH
Market value$114.88M
25.17%
Sole
7.18M
Shared
0.00
None
0.00
KLAVIYO INC
SOLEShares3.52M
TypeSH
Market value$97.33M
21.33%
Sole
3.52M
Shared
0.00
None
0.00
BETA BIONICS INC
SOLEShares3.57M
TypeSH
Market value$70.94M
15.54%
Sole
3.57M
Shared
0.00
None
0.00
COUPANG INC
SOLEShares795.01K
TypeSH
Market value$25.60M
5.61%
Sole
795.01K
Shared
0.00
None
0.00
DOORDASH INC
SOLEShares90.14K
TypeSH
Market value$24.52M
5.37%
Sole
90.14K
Shared
0.00
None
0.00
SAMSARA INC
SOLEShares598.91K
TypeSH
Market value$22.31M
4.89%
Sole
598.91K
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares10.95M
TypeSH
Market value$17.74M
3.89%
Sole
10.95M
Shared
0.00
None
0.00
DATADOG INC
SOLEShares118.71K
TypeSH
Market value$16.90M
3.70%
Sole
118.71K
Shared
0.00
None
0.00
MONDAY COM LTD
SOLEShares58.34K
TypeSH
Market value$11.30M
2.48%
Sole
58.34K
Shared
0.00
None
0.00
TARSUS PHARMACEUTICALS INC
SOLEShares170K
TypeSH
Market value$10.10M
2.21%
Sole
170K
Shared
0.00
None
0.00
CROWDSTRIKE HLDGS INC
SOLEShares15.62K
TypeSH
Market value$7.66M
1.68%
Sole
15.62K
Shared
0.00
None
0.00
SNOWFLAKE INC
SOLEShares27K
TypeSH
Market value$6.09M
1.33%
Sole
27K
Shared
0.00
None
0.00
ACUMEN PHARMACEUTICALS INC
SOLEShares3.42M
TypeSH
Market value$5.84M
1.28%
Sole
3.42M
Shared
0.00
None
0.00
TOAST INC
SOLEShares156.60K
TypeSH
Market value$5.72M
1.25%
Sole
156.60K
Shared
0.00
None
0.00
10X GENOMICS INC
SOLEShares481.77K
TypeSH
Market value$5.63M
1.23%
Sole
481.77K
Shared
0.00
None
0.00
BIOAGE LABS INC
SOLEShares786.35K
TypeSH
Market value$4.62M
1.01%
Sole
786.35K
Shared
0.00
None
0.00
ACRIVON THERAPEUTICS INC
SOLEShares2.12M
TypeSH
Market value$3.84M
0.84%
Sole
2.12M
Shared
0.00
None
0.00
TAYSHA GENE THERAPIES INC
SOLEShares724.87K
TypeSH
Market value$2.37M
0.52%
Sole
724.87K
Shared
0.00
None
0.00
CANDEL THERAPEUTICS INC
SOLEShares405.84K
TypeSH
Market value$2.07M
0.45%
Sole
405.84K
Shared
0.00
None
0.00
FIGMA INC
SOLEShares18.29K
TypeSH
Market value$948.5K
0.21%
Sole
18.29K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
NU HLDGS LTDSOLE | ORD SHS CL A | 7.18M | SH | $114.88M 25.17% | 7.18M | 0.00 | 0.00 |
KLAVIYO INCSOLE | COM SER A | 3.52M | SH | $97.33M 21.33% | 3.52M | 0.00 | 0.00 |
BETA BIONICS INCSOLE | COM | 3.57M | SH | $70.94M 15.54% | 3.57M | 0.00 | 0.00 |
COUPANG INCSOLE | CL A | 795.01K | SH | $25.60M 5.61% | 795.01K | 0.00 | 0.00 |
DOORDASH INCSOLE | CL A | 90.14K | SH | $24.52M 5.37% | 90.14K | 0.00 | 0.00 |
SAMSARA INCSOLE | COM CL A | 598.91K | SH | $22.31M 4.89% | 598.91K | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 10.95M | SH | $17.74M 3.89% | 10.95M | 0.00 | 0.00 |
DATADOG INCSOLE | CL A COM | 118.71K | SH | $16.90M 3.70% | 118.71K | 0.00 | 0.00 |
MONDAY COM LTDSOLE | SHS | 58.34K | SH | $11.30M 2.48% | 58.34K | 0.00 | 0.00 |
TARSUS PHARMACEUTICALS INCSOLE | COM | 170K | SH | $10.10M 2.21% | 170K | 0.00 | 0.00 |
CROWDSTRIKE HLDGS INCSOLE | CL A | 15.62K | SH | $7.66M 1.68% | 15.62K | 0.00 | 0.00 |
SNOWFLAKE INCSOLE | COM SHS | 27K | SH | $6.09M 1.33% | 27K | 0.00 | 0.00 |
ACUMEN PHARMACEUTICALS INCSOLE | COM | 3.42M | SH | $5.84M 1.28% | 3.42M | 0.00 | 0.00 |
TOAST INCSOLE | CL A | 156.60K | SH | $5.72M 1.25% | 156.60K | 0.00 | 0.00 |
10X GENOMICS INCSOLE | CL A COM | 481.77K | SH | $5.63M 1.23% | 481.77K | 0.00 | 0.00 |
BIOAGE LABS INCSOLE | COM | 786.35K | SH | $4.62M 1.01% | 786.35K | 0.00 | 0.00 |
ACRIVON THERAPEUTICS INCSOLE | COMMON STOCK | 2.12M | SH | $3.84M 0.84% | 2.12M | 0.00 | 0.00 |
TAYSHA GENE THERAPIES INCSOLE | COM SHS | 724.87K | SH | $2.37M 0.52% | 724.87K | 0.00 | 0.00 |
CANDEL THERAPEUTICS INCSOLE | COM | 405.84K | SH | $2.07M 0.45% | 405.84K | 0.00 | 0.00 |
FIGMA INCSOLE | CLASS A COM STK | 18.29K | SH | $948.5K 0.21% | 18.29K | 0.00 | 0.00 |